돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HCID 6076생성일: 2026년 10월 26일

3′,5′-사이클릭아데닐산

3′,5′-사이클릭아데닐산 · 아데노신사이클릭포스페이트 · CAMP · ADENOSINE CYCLOPHOSPHATE · Acrasin · ADENOSINE CYCLPHOSPHATE · Adenosine 3',5'-cyclophosphate · (4aR,6R,7R,7aS)-6-(6-Amino-9H-purin-9-yl)-2,7-dihydroxytetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphinine 2-oxide

https://huagongshe.com/ko/chemical/6076

3′,5′-사이클릭아데닐산 분자 구조식

식별자 및 물리적 특성

CAS No.60-92-4
분자식C10H12N5O6P
평균 분자량329.21 g/mol
단동위원소 질량329.05251973 g/mol
SMILESNc1ncnc2c1ncn2[C@@H]1O[C@@H]2COP(=O)(O)O[C@H]2[C@H]1O
InChIKeyIVOMOUWHDPKRLL-KQYNXXCUSA-N
PubChem CID6076
ChEMBLCHEMBL316966
ChEBICHEBI:17489
EC No.200-492-9
DTXSIDDTXSID8040436
현지명3′,5′-사이클릭아데닐산

화학 및 물리적 성질

XLogP-2.6
극성 표면적155
수소 결합 공여자 수3
수소 결합 수용자 수10
회전 가능 결합 수1
무거운 원자 수22
형식 전하0
복잡도498
의약품Pharmaceuticals -> Listed in ZINC15
화장품Skin conditioning
LogP(분배 계수)-2.96
용해도4 mg/mLH2O: 10 mg/mL 수용액의 pH는 대략입니다. 3.0. 나트륨염(A6885)은 약 20×입니다.
녹는점219-220 °C219 - 220 °C260 °C (dec.)(lit.)
Physical DescriptionSolid
Collision Cross Section176.8 Ų [M+H]+ [CCS Type: DTMethod: single field calibrated with Agilent tune mix (Agilent)]172 Ų [M+H]+ [CCS Type: TWMethod: calibrated with polyalanine]175.07 Ų [M-H]- [CCS Type: DTMethod: stepped-field]188.8 Ų [M+Na]+ [CCS Type: DTMethod: single field calibrated with ESI Low Concentration Tuning Mix (Agilent)]181.3 Ų [M+Na]+
끓는 점56.12°C
밀도2.47±0.1 g/cm3(Predicted)
저장 조건-20°C
pKa(산도 계수)1.00±0.60(Predicted)
물리적 상태가루
색상하얀색
생물학적 소스mouse
용해도50mg/mL
Merck14,2708
BRN52645
안정성흡습성
화장품 원료 기능피부 컨디셔닝
InChI1S/C10H12N5O6P/c11-8-5-9(13-2-12-8)15(3-14-5)10-6(16)7-4(20-10)1-19-22(17,18)21-7/h2-4,6-7,10,16H,1H2,(H,17,18)(H2,11,12,13)/t4-,6-,7-,10-/m1/s1
InChIKeyIVOMOUWHDPKRLL-KQYNXXCUSA-N
SMILESNc1ncnc2n(cnc12)[C@@H]3O[C@@H]4COP(O)(=O)O[C@H]4[C@H]3O
NISTAdenosine 3',5'-cyclic monophosphate(60-92-4)
EPAAdenosine, cyclic 3',5'-(hydrogen phosphate) (60-92-4)

화학적 성질

White crystalline or Pale yellow powder; odorless. Slightly soluble in water, almost insoluble in ethanol or ether.

안전 및 규제

GHS 분류This chemical does not meet GHS hazard criteria for 33.3% (2 of 6) of reports.DangerH314 (16.7%): Causes severe skin burns and eye damage [Danger Skin corrosion/irritation]P260, P261, P264, P264+P265, P271, P280, P301+P330+P331, P302+P352, P302+P361+P354, P304+P340, P305+P351+P338, P305+P354+P338, P316, P317, P319, P321, P332+P317, P337+P317, P362+P364, P363, P403+P233, P405, and P501 (click each P-code to see the statement)Aggregated GHS information provided per 6 reports by companies from 3 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
규제 정보Chemical: Adenosine, cyclic 3',5'-(hydrogen phosphate)Adenosine, cyclic 3',5'-(hydrogen phosphate): Does not have an individual approval but may be used as a component in a product covered by a group standard. It is not approved for use as a chemical in its own right.
기타 안전 정보IMAP assessments - Adenosine, cyclic 3',5'-(hydrogen phosphate): Environment tier I assessment
Hazard Classes and CategoriesSkin Corr. 1B (16.7%)
수질 위해 등급(WGK)3
TSCA 등재 상태TSCA listed
RTECS 번호AU7357600
독성oms-hmn:oth 100 mmol/L JIDEAE 65,52,75
관세 코드29349990
위험 문구(R)34-36/37/38
위험 표시C,Xi
안전 문구(S)22-24/25-45-36/37/39-26-36
F 고인화성물질10-21
저장 분류11 - Combustible Solids

용도

용도

cAMP is used for intracellular signal transduction in many different organisms, conveying the cAMP-dependent pathway. Restoration of several morphological characteristics of normal fibroblasts in sarcoma cells when treated with adenosine-3': 5'-cyclic monophosphate. In the presence of adenosine 3':5'-cyclic monophosphate, protein kinase I dissociated into two subunits: a subunit binding adenosine 3':5'-cyclic monophosphate, and a catalytic subunit. Stimulation of calcium uptake in platelet membrane vesicles by adenosine 3',5'-cyclic monophosphate.

일반 설명

Cyclic AMP is a second messenger molecule comprised of an adenine ribonucleotide bearing a phosphate group bound to the oxygen molecules at the 3' and 5' positions of the sugar moiety. Cyclic AMP, which is synthesized from ATP by the intracellular enzyme adenylate cyclase, modulates the activity of several hormone-dependent signal transduction pathways.